FDA Inspection 1265185 — New York Reproductive Wellness Medicine, P.C.

New York Reproductive Wellness Medicine, P.C. — FEI 3010122933

The FDA completed an inspection of New York Reproductive Wellness Medicine, P.C. on March 28, 2025 in Syosset, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 28, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Syosset, NY (United States)

Citations

IDCFRDescription
1249321 CFR 1271.90(c)Eligibility not required--warning labels